As of 2025-09-18, the Intrinsic Value of Amgen Inc (AMGN) is 319.11 USD. This Amgen valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 274.71 USD, the upside of Amgen Inc is 16.20%.
The range of the Intrinsic Value is 189.45 - 711.54 USD
Based on its market price of 274.71 USD and our intrinsic valuation, Amgen Inc (AMGN) is undervalued by 16.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 189.45 - 711.54 | 319.11 | 16.2% |
| DCF (Growth 10y) | 241.92 - 807.40 | 383.53 | 39.6% |
| DCF (EBITDA 5y) | 157.32 - 219.17 | 185.74 | -32.4% |
| DCF (EBITDA 10y) | 215.85 - 313.98 | 260.02 | -5.3% |
| Fair Value | 61.47 - 61.47 | 61.47 | -77.62% |
| P/E | 129.38 - 183.68 | 157.25 | -42.8% |
| EV/EBITDA | 111.16 - 164.83 | 134.08 | -51.2% |
| EPV | 141.84 - 231.08 | 186.46 | -32.1% |
| DDM - Stable | 101.24 - 331.09 | 216.17 | -21.3% |
| DDM - Multi | 113.23 - 294.16 | 164.26 | -40.2% |
| Market Cap (mil) | 147,892.88 |
| Beta | 0.39 |
| Outstanding shares (mil) | 538.36 |
| Enterprise Value (mil) | 196,068.88 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.42% |
| Cost of Debt | 5.35% |
| WACC | 8.08% |